Company

InkVivo Technologies AG

Biotechnology Research H22, Ch 7 employees

Employees: 7
Contacts: 4
Emails: 4
Phones: 2

inkvivo.tech LinkedIn Crunchbase

InkVivo Technologies AG Overview

Headquarters: H22, Ch
Website: inkvivo.tech
Industry: Biotechnology Research
Employees: 7
Founded: 2023
Funding: 5.0K
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biomaterials Gastroretentive formulations Drug formulations Injectable formulations Advanced manufacturing nano/micro encapsulation Drug reformulation Patient centric therapies

About InkVivo Technologies AG

InkVivo leverages scalable manufacturing approaches with its biomaterial platform to fabricate innovative drug delivery systems. Our unique ability relies in controlling the spatial composition and formulation of the designed systems, which result in targeted and temporal controlled release of active ingredients (e.g., small molecules, biologics, and micronutrients) increasing their bioavailability. InkVivo provides: 1) Enginering support for (new) drug development; 2) Reformulation and relaunching existing drug delivery systems; and 3) Life cycle management of existing drugs

InkVivo Technologies AG Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 2; 50.0% coverage

InkVivo Technologies AG Org Chart

Sample employees and titles

Name	Title	Location	Contact
Grégoire Schwach	Pharmaceutical R&D Leader	Neuchâtel, Switzerland	Email
Fabio Rupp	Biotech Consultant	San Francisco Bay Area, United States	Email Phone
Marco Ziegler	Senior Advisor, Board Member, Senior	Zurich, Switzerland	Email Phone
Lorenzo Leoni	Scientific Serial Entrepreneur	Lugano Metropolitan Area, Switzerland	Email